EFI
JAZZ icon

EHP Funds Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

EHP Funds Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$570K Buy
+3,350
New +$514K 1.3% 20

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EHP Funds Inc's JAZZ Position: Q4 2025 in Review

EHP Funds Inc opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2025: 3,350 shares worth $570K. The stake represents 1.3% of the portfolio and ranks #20 among its holdings.

573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • EHP Funds Inc held 3,350 shares of Jazz Pharmaceuticals worth $570K as of Q4 2025.
  • Jazz Pharmaceuticals was a new EHP Funds Inc position in Q4 2025.
  • Jazz Pharmaceuticals made up 1.3% of EHP Funds Inc's portfolio in Q4 2025, its #20 holding.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on EHP Funds Inc's 13F filing for Q4 2025, filed 12 Feb 2026.